Testicular pathology in 46, XY dysgenetic male pseudohermaphroditism: An approach to pathogenesis of testis cancer

Journal of Andrology

Volumn 22, Issue 5, 2001, Pages 781-792

  Slowikowska Hilczer, J ^a   Szarras Czapnik, M ^a   Kula, K ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Gonadal dysgenesis; Gonadotropins; Testicular carcinoma in situ

Indexed keywords

ARTICLE; CANCER RISK; CHILD; CLINICAL ARTICLE; CORRELATION FUNCTION; GONADAL DYSGENESIS; HUMAN; HUMAN TISSUE; HYPOSPADIAS; INFANT; MALE; MALE PSEUDOHERMAPHRODITISM; PRIORITY JOURNAL; TESTIS CANCER; TESTIS CARCINOMA; TESTOSTERONE RELEASE;

CHILD; CHILD, PRESCHOOL; FOLLICLE STIMULATING HORMONE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; KARYOTYPING; LUTEINIZING HORMONE; MALE; PSEUDOHERMAPHRODITISM; TESTICULAR NEOPLASMS; TESTIS;

EID: 0034857437     PISSN: 01963635     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Testicular nonseminoma and seminoma in relation to perinatal characteristics
2. Spermatogenic onset. II. FSH modulates mitotic activity of germ and Sertoli cells in immature rats
3. Localization of human follicle-stimulating hormone in testis
4. Serum FSH and testicular morphology in male infertility
5. Abnormalities of gonadal differentiation
6. Androgen receptor structure, function, regulation, and dysfunction
7. 10
8. Androgen receptor gene mutations in 46, XY females with germ cell tumors
9. Müllerian inhibiting substance: Gene structure and mechanism of action of fetal regressor
10. Pathogenesis of adult germ cell tumours. A cytogenetic model
11. Difference in DNA index of seminomas and nonseminomas
12. Evidence for a stimulatory role of follicle-stimulating hormone on the spermatogonial population in adult males
13. Androgen receptor levels and 5α-reductase activities in prepubertal skin and chordee tissue of boys with isolated hypospadias
14. Placental-like alkaline phosphatase as a marker of carcinoma-in-situ of the testis. Comparison with monoclonal antibodies M2A and 43-9F
15. Testicular changes associated with the initiation of spermatogenesis
16. Disorders of sex differentiation
17. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis
18. Germ cell neoplasms arising in gonadoblastomas
19. Morphology of normal and malignant germ cells
20. Immunohistochemical demonstration of placental alkaline phosphatase in various states of testicular development and in germ cell tumours
21. Immunohistochemical markers of carcinoma in situ of the testis also expressed in normal infantile germ cells
22. DNA content and expression of tumour markers in germ cells adjacent to germ cell tumours in childhood: Probably a different origin for infantile and adolescent germ cell tumours
23. Heterogeneity of gonadoblastoma germ cells: Similarities with immature germ cells, spermatogonia and testicular carcinoma in situ cells
24. Alteration of Sertoli cell differentiation in the presence of carcinoma in situ in human testes
25. A mutation in the follicle stimulating hormone receptor occurs frequently in human ovarian sex cord tumors
26. GnRH test reveals changes of testosterone and estradiol secretion potential in boys with bilateral cryptorchism
27. Hormonal disturbances in boys with hypospadias
28. Hormonal control of spermatogenesis: Circulating hormones versus quantitation of germinal cells in testicular tissue
29. Hyperactivation of early steps of spermatogenesis compromises meiotic insufficiency in men with hypergonadotropism. A possible quantitative assay for high FSH/low testosterone availabilities
30. Candidate genes in complete and partial XY sex reversal: Mutation analysis of SRY, SRY-related genes and FTZ-F1
31. Testicular seminoma in a patient with a constitutively activating mutation of the luteinizing hormone/chorionic gonadotropin receptor
32. Microspectrophotometric DNA measurements of carcinoma-in-situ germ cells in the testis
33. Testicular carcinoma in situ in children with the androgen insensitivity (testicular feminisation) syndrome
34. Carcinoma in situ of the testis in children with 45, X/46, XY gonadal dysgenesis
35. Abnormal infantile germ cells and development of carcinomain-situ in maldeveloped testes: A stereological and densitometric study
36. Management of males with 45, X/46, XY gonadal dysgenesis
37. Testicular tumour associated with hormonal treatment for oligospermia
38. Morphological and histometric study on the human Sertoli cell from birth to the onset of puberty
39. The possible role of sex hormones in the development of testicular cancer
40. Heterogeneity of expression of immunohistochemical tumour markers in testicular carcinoma in situ: Pathogenetic relevance
41. Testicular dysgenesis does not affect expression of anti-Müllerian hormone by Sertoli cells in pre-meiotic seminiferous tubules
42. Evaluation of gonadal function in 107 intersex patients by means of serum antimüllerian hormone measurement
43. Cytophotometric measurements of the DNA content of human malignant tumours by means of the Feulgen reaction
44. Gonadoblastoma. A review of 74 cases
45. Neoplasia associated with anomalous sexual development and abnormal sex chromosomes
46. Clinical evaluation and management of testicular disorders before puberty
47. Possible carcinoma-in-situ of the testis
48. Histopathology of human testicular tumours: Carcinoma-in-situ germ cells and invasive growth of different types of germ cell tumours
49. Carcinoma-in-situ of the testis: Possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma
50. The pathology of gonadal neoplasms composed of germ cells and sex cord stroma derivatives
51. Follicle stimulating hormone stimulates spermatogenesis in the adult monkey
52. Abnormal sexual differentiation and neoplasia
53. Steroid 5α-reductase: One disorder/two enzymes/many unsolved problems
54. Immunohistochemical localization of hFSH as an index of Sertoli cell function in the human testis